← All trials
NCT02414581
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2015
- Primary completion
- Aug 1, 2016
- Completion date
- Sep 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital Regional Alta Especialidad BajioLead sponsor
- Hospital Regional Alta Especialidad BajioOverall official - principal investigator
- Hospital Regional Alta Especialidad BajioReponsible party - principal investigator
- Universidad de GuanajuatoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.